In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Validation ? a short guide part III Formal requirements of the Polish Patent Office to file validation

Validating European Patent in Poland seems to be a fairly simple task. However, one should Czytaj dalej

Patpol as a thematic partner at the 9th International Congress of Family Businesses

We are happy to return to meetings with our clients and partners during stationary events. Czytaj dalej

Using a trademark in different form than registered and proofs of genuine use – part 2

The First Board of Appeal of the European Union Intellectual Property Office (EUIPO) presented its Czytaj dalej